📰 All News
Life Science & Pharma News
The latest pharmaceutical, biotechnology, MedTech, and healthcare news and analysis from Ireland, the EU, and globally.
224
Articles
19
Pages
IE
Ireland first
MedTech
Mergon Acquires Enniscrone Healthcare Moulder Inmo Tech
Westmeath-based Mergon Group has completed the acquisition of Inmo Tech, a specialist injection moulder in Enniscrone, Co Sligo, whose customers are mainly in medical and healthcare. We set out what each company brings and what the deal means for the North-West.
Regulatory Affairs
HSE Weighs Mounjaro Funding: What the NCPE Numbers Show
A HSE expert group is considering whether Mounjaro (tirzepatide) should be funded for weight management, after Eli Lilly's price offer. We set out the NCPE figures, the eligibility options and what a decision would mean.
Regulatory Affairs
Ireland Publishes National Drugs Strategy 2026-2030
Ireland's National Drugs Strategy 2026-2030 and its first action plan, with 33 actions to 2028, set out a health-led response to drug and alcohol harms, backed by EUR 7 million in Budget 2027.
Pharmaceutical
Millicent Pharma Invests Millions in Larne, Creating 20 Jobs
Carlyle-backed women's health company Millicent Pharma is making a multimillion pound investment in automation and capacity at its Larne plant, creating more than 20 jobs and taking the site's workforce from 50 to 70.
Regulatory Affairs
European Health Data Space: Ireland Hosts EU Health Leaders
Ireland's EU Council Presidency hosts a flagship European Health Data Space conference at Croke Park, Dublin, on 13 October 2026, bringing health ministries, regulators, patients, researchers and industry together on how the EHDS is put into practice.
Industry
Budget 2027: €29.1bn for Health, Rare Disease Medicines Pilot
Ireland's Budget 2027 allocates €29.1 billion to health, an increase of €1.76 billion, with a pilot for earlier access to rare disease medicines, a national shingles vaccination programme and more evening and weekend care.
Industry
Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns
A new EGFSN report says Ireland will need 215,400 digital specialists by 2030 and could be short up to 7,700 a year. It lands as the Citizenship Bill 2026 would raise the residence requirement from five to eight years.
Industry
Project Management Failures: Lessons for Healthcare
The national children's hospital, now sanctioned at €2.24bn, shows the same project management failures as MetroLink, BusConnects, DART+ and Stuttgart 21. A fact-checked look at the figures, the organisations involved and what healthcare project managers can change.
Regulatory Affairs
FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli
The FDA approved Onswik (insulin efsitora alfa-gobe), Eli Lilly's once-weekly basal insulin for adults with type 2 diabetes, on 24 September 2026, six months after Novo Nordisk's Awiqli. The trials, the label warning and what it means in Ireland.
Industry
WeBuild Programme: 50+ Women-Led Ventures and How to Apply
The WeBuild programme has now supported more than 50 women-led tech ventures across the island of Ireland. Eligibility, Cohort 4 dates, how it compares with NextWave and NDRC, and what health founders should know before the 30 October 2026 deadline.
Pharmaceutical
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity
Astellas Ireland will install a second aseptic filling line at its Kerry Technology Park facility in Tralee, doubling drug-product manufacturing capacity and adding skilled roles by 2029. The 330 million euro plant announced in 2023 is due to open in early 2027.
Industry
Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing
Irish specialty pharmaceutical company Xeolas Pharmaceuticals officially opens a new 158,000 square foot state-of-the-art facility in Baldoyle, Dublin. The site unifies research, development, formulation, clinical supply, and commercial manufacturing for over 25 pipeline products across 21 countries.